Gene Query: CBX4

Dataset Description Geneva Score
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 70.84
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 47.29
Gene expression analysis of dengue-infected cells 45.43
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 45.33
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 44.95
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 44.77
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 44.35
Effect of BMP inhibition or stimulation of primary human keratinocytes 44.35
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 43.13
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 43.13
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 41.96
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 41.96
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 41.59
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 40.2
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 39.52
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 35.99
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 35.18
LNCaP treated with iBET 34.62
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 33.95
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 30.77
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 29.73
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 29.73
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 29.7
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 27.96
RNAseq of IL-36 stimulated primary human keratinocytes 26.93
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 24.51
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 24.51
The comparison of high-throughput single-cell RNA-seq methods 24.22
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 24.18
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 23.85
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 22.76
Human HAP1 cells before and after nutrient deprivation 22.69
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 22.69
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 22.41
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 21.94
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 21.82
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 21.81
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 21.73
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 21.2
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 20.96
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 20.9
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 20.6
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 20.09
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 19.65
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 19.65
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 19.18
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 19.18
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 18.87
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 18.67
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 18.39
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 18.18
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 18.18
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 17.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 17.28
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 17.09
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 17.04
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 17.0
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 16.9
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 16.7
LncRNA-GAS5 negative regulation of YAP-target genes expression 16.41
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 16.28
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 16.28
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 16.09
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 16.08
R430: A potent inbibitor of DNA and RNA viruses 15.82
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 15.7
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 15.68
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 15.58
Transcriptional profiling of LS1034 cells treated with tepoxalin 15.57
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 15.37
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 15.31
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 15.27
Genome-wide analysis of Dengue virus 2 infected cells 15.05
Lipid degradation promotes prostate cancer cell survival 15.03
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 14.96
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 14.9
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 14.87
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 14.82
The role of FAM46C in myeloma cells 14.77
The role of FAM46C in myeloma cells [sequencing] 14.77
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 14.58
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 14.58
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 14.33
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 14.28
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 14.23
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 14.19
Gene expression profiling of leukemia cells following asparagine depletion 13.98
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 13.93
Transcriptome analysis in Neobractatin treated cells 13.91
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 13.79
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 13.69
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 13.61
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.58
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 13.5
Gene expression in PANC1 cells treated with Rakicidin 13.49
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 13.47
A Unique Epigenomic Landscape Defines Human Erythropoiesis 13.47
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 13.43
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 13.4
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 13.36
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 13.27
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 13.27
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 13.16
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 13.16
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 13.11
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 13.1
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 13.1
RNA sequencing of GlyH-101-treated MCF-7 cell line 13.01
Gene expression changes after LOC550643 silencing 12.98
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 12.96
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 12.92
Gene Expression Profiling of WT and KDM3A Knocked out Cell 12.92
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 12.88
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 12.86
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 12.86
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 12.85
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 12.84
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 12.62
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 12.61
Effect of ILF3 on translation during homeostasis and the antiviral response 12.58
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 12.39
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 12.39
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 12.35
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 12.35
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 12.35
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 12.32
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 12.32
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 12.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 12.31
MAIT cell RNA sequencing 12.22
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.88
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 11.76
MOF acetyl transferase regulates transcription and respiration in mitochondria 11.72
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 11.66
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 11.56
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 11.48
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 11.42
The evolution of N6-methyladenosine in primates 11.29
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 11.16
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 11.1
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 11.07
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 10.99
Polarized B -cell functions 10.95
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 10.93
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 10.91
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 10.88
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 10.88
ARID1A and ARID1B loss in HCT116 and TOV21G cells 10.72
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 10.67
Hepatitis C virus functionally sequesters miR-122 10.63
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 10.63
Identification of Sin3B regulated genes during quiescence 10.58
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 10.56
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 10.53
Primary Human B-cell Temporal Response to CD40L Stimulation 10.44
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 10.28
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 10.24
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 10.17
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 10.09
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 10.0
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 10.0
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 9.99
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  9.95
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 9.94
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.93
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 9.93
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 9.9
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 9.9
Intrahepatic MAIT cell gene expression revealed by RNA-seq 9.89
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 9.86
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 9.86
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 9.81
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 9.81
Transcriptome analysis of Zika infected neural stem cells 9.75
Zika infected neural stem cells 9.75
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 9.75
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 9.75
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.73
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 9.71
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.7
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 9.68
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 9.59
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 9.48
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 9.48
Effect of Influenza virus infection on lncRNA expression in A549 cells 9.44
Transcriptional profile in human S. haematobium infection 9.32
Single-nucleotide-resolution mapping of HBV promoters using CAGE 9.32
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 9.31
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 9.25
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 9.23
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 9.19
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.18
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 9.18
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 9.17
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 8.99
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 8.99
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 8.97
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 8.95
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.94
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 8.92
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 8.89
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 8.89
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 8.88
Co-regulation of splicing by Rbfox1 and hnRNP M 8.88
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 8.88
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.85
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 8.84
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 8.8
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 8.77
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 8.76
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 8.75
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 8.7
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 8.69
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 8.67
MeRIP-seq for heat shock in B-cell lymphoma cells 8.66
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.64
Overexpression of NFIB and YBX1 in MCF-7 cells 8.61
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 8.6
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 8.59
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 8.51
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 8.49
RNA-seq analyses of human prostate cancer cells 8.49
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 8.38
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 8.37
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.3
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.3
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.26
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.26
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.26
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 8.22
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 8.08
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 8.07
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 8.06
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.04
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 8.04
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 8.0
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.99
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.87
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 7.84
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 7.84
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 7.81
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 7.78
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 7.73
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 7.73
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.72
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 7.67
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 7.66
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 7.5
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 7.48
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.47
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 7.43
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 7.42
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 7.32
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 7.29
U1 snRNP telescripting regulates size-function stratified human genome 7.28
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 7.27
Expression data from miR340 overexpressing human A549 cells 7.26
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.18
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.13
A prostate cancer chromatin interaction map 7.12
RNA-sequencing of human liver tissue 7.08
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.07
Biological effect of chronic mistranslation in mammalian cells 6.97
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.95
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.95
Expression profiling of MCF-7 cells with treatment of TCDD 6.91
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 6.91
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 6.85
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 6.85
Patient-derived luminal breast cancer xenografts with progestins 6.84
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.84
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.77
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 6.74
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 6.66
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 6.63
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.62
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 6.62
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 6.62
Uridylation by TUT4 and TUT7 marks mRNA for degradation 6.57
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 6.53
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.52
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 6.5
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.49
Regulation of highly expressed hCINAP on translatome 6.49
Controlling for gene expression changes in transcription factor protein networks. 6.48
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 6.46
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.37
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.28
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.28
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 6.25
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.13
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.13
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 6.12
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 6.11
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 6.1
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 6.1
RNA sequencing of human mammary epithelial cells 6.08
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.03
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 5.93
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 5.93
BASP1 modifies the Tamoxifen response 5.9
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 5.88
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 5.85
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 5.85
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 5.84
Genome-wide analysis of the Integrator complex 5.79
Genome-wide analysis of the Integrator complex (HTS) 5.79
The DPYSL2 gene connects mTOR and schizophrenia 5.74
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.74
Transcriptome profiling of Normal and Cancerous Prostate Cells 5.73
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.69
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.69
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 5.64
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 5.64
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 5.61
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 5.57
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 5.54
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 5.51
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.48
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.46
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 5.45
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 5.4
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 5.3
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 5.29
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.26
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 5.26
Gene expression profile of multiple myeloma cell lines treated with CB-5083 5.24
RNA-Seq analysis of breast cancer cells after shikonin treatment 5.19
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 5.19
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 5.11
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.02
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 5.0
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 4.93
m6A-dependent regulation of messenger RNA stability 4.92
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.87
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.85
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.84
A549 cell transcriptome responses to infection with H7N9 influenza virus 4.84
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 4.79
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.79
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 4.71
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.62
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 4.6
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 4.53
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 4.52
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 4.52
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 4.52
Identification of HOXB13 target genes responsive to BET inhibitors 4.47
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.46
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 4.45
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.38
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 4.36
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 4.36
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.35
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 4.35
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.33
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 4.33
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 4.32
Regulating Interleukin-2 activity with engineered receptor signaling clamps 4.3
The bromodomain protein BRD4 regulates splicing during heat shock 4.28
Gene expression changes upon drug withdrawal (Mel888 cell line) 4.23
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.23
RNA seq with AML (NB4) cells upon FTO inhibition 4.21
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 4.18
CDK12 mediated transcriptional regulation in U2OS cells 4.13
Genome-wide Analysis of Chromatin Interactions in Human Cells 3.96
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.96
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 3.92
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 3.9
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.88
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.81
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 3.79
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.73
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 3.71
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 3.7
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.59
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.56
RNA-seq of naive and primed ES cells 3.55
Dissecting neural differentiation regulatory networks through epigenetic footprinting 3.46
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 3.43
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 3.43
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.4
Transcriptome Profiling of Human Primary Monocytes 3.39
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.37
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.37
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 3.35
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 3.35
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.34
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.34
Gene expression analysis of breast cancer cell-lines 3.34
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.34
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.34
Capturing the Interactome of Newly Transcribed RNA 3.34
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.34
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 3.3
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.19
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 3.16
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.1
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.1
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 3.09
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 3.09
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.06
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 3.05
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.03
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.02
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.0
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 2.93
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 2.85
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 2.82
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 2.82
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.76
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 2.76
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.74
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.72
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.65
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.65
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.64
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.64
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 2.62
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.56
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 2.5
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.47
CD86 regulates a pro-survival signal in myeloma cells 2.47
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 2.44
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 2.44
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 2.44
SLAM-seq for K562 endogenous mRNA decay 2.44
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.4
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.39
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.32
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.32
Cell responses to dysregulated VZV-induced cell-cell fusion 2.31
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.24
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.17
Disruption of GRIN2B impairs differentiation in human neurons 2.14
Regulation of poly(A) tail and translation during the somatic cell cycle 2.08
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.03
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.03
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 2.02
The circadian transcriptional landscape in primary human mammary epithelial cells 1.96
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.96
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 1.96
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.87
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.86
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.86
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.82
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 1.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.8
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.77
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.74
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.74
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.68
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.65
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.63
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.63
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.62
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.62
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.6
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.58
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.53
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 1.52
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 1.52
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.51
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.51
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.51
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.34
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 1.33
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.33
Effect of FGF13 depletion on the H460 cell line 0.96
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.89
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.87
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.83
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.78
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.75
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.69
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.69
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.67
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 0.64
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.56
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.56
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.54
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.5
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.47
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.46
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.43
Finding missing proteins from epigenetically manipulated human cells 0.43
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.38
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.36
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.24
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.24
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.23
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.18
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.18
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.17
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.14
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.03
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.03
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.02
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation